article thumbnail

Assessing the Accuracy of Pharmaceutical-Sponsored Health Information Online

Pharma Marketing Network

The internet is a vast resource of information on health and wellness. However, not all of this information is created equal. Some of it is accurate and reliable, while other information may be misleading or even harmful. This is especially true when it comes to pharmaceutical-sponsored health information.

article thumbnail

STAT+: Sanofi plans to change payment terms for 340B hospitals

STAT

The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceutical company to disclose plans to change the way it will make payments.

Hospitals 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EU expands accessibility of product information for medicines with electronic format

Hospital Pharmacy Europe

Electronic product information (ePI) for selected human medicines has been published for the first time by the Heads of Medicines Agencies (HMA), the European Commission (EC) and the European Medicines Agency (EMA). According to the EMA, outcomes will inform how to integrate the ePIs into common practice and expand their use across the EU.

article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

article thumbnail

Scientists want to put carbon footprints on drugs. But it’s hard to get accurate numbers

STAT

Anyone picking up a prescription from their pharmacy is used to the reams of paper that typically accompany it: information on safety, storing, and how to use the drug. What if that information also included your medicine’s carbon footprint?

article thumbnail

Opinion: STAT+: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma

STAT

The BIOSECURE Act would prohibit many biotech and pharmaceutical companies from conducting certain research and development activities, including the manufacturing of drugs through named Chinese companies. Protecting that information and being able to make our own medicines should be a national priority.

article thumbnail

ePI rollout backed in new paper by pharmaceutical bodies

European Pharmaceutical Review

Three industry bodies have produced a joint position paper highlighting recommendations for adopting a harmonised implementation of electronic Product Information (ePI) leaflets. It will also enable more patient-centric and accessible content by providing the most up-to-date information.